CEO: Ara Katz Lead Investor: Marlon Nichols

Seed is an ecosystem of scientists, doctors, innovators, thinkers, and translational storytellers, pioneering the inquiry and application of microbiome science to improve human and planetary health. The microbiome marks an evolution of health—both within and beyond our bodies. New technologies and research inform that each one of us is a vast and complex ecosystem. The new biology reveals the potential of bacteria to restore and sustain the systemic health of ourselves and our environment, radically transforming our approach to medicine, hygiene, diet, and living. Seed’s Scientific Advisory Board is comprised of scientists, researchers, doctors, and authors across the fields of microbiology, immunology, genetics, metabolomics, gastroenterology, pediatrics, molecular biology, and transcriptomics—including primary investigators from the NIH’s Human Microbiome Project. They lead labs, teach at world-renowned academic institutions, and have among them 2800+ publications and over 140,000 citations in peer-reviewed scientific journals and textbooks.

Latest Company Updates

Industry Coverage

This field guide teaches companies how they can go carbon negative


Seed Health wants to use bacteria to stop premature births and curb plastic waste. We got a peek at the slides it used to raise $40 million.


Startups Wrap Brand Identity With Sustainable Packaging


Microbiome Company Seed™ Launches to Disrupt Probiotics, Set New Industry Standards


Seed Is Hiring

No Available Positions
View More Portfolio Companies
Select Another Portfolio Company